Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000155347 | SCV000205033 | uncertain significance | not specified | 2014-02-01 | criteria provided, single submitter | clinical testing | The Arg653Cys variant in WFS1 has not been previously reported in individuals wi th hearing loss. This variant has been identified in 0.035% (3/8600) of European American chromosomes by the NHLBI Exome Sequencing Project (http://evs.gs.washi ngton.edu/EVS/; dbSNP rs201064551). Computational analyses (biochemical amino ac id properties, conservation, AlignGVGD, PolyPhen2, and SIFT) do not provide stro ng support for or against an impact to the protein. In summary, additional infor mation is needed to determine the clinical significance of this variant. |
Gene |
RCV000767006 | SCV000252535 | uncertain significance | not provided | 2022-06-08 | criteria provided, single submitter | clinical testing | Identified in an individual with hearing loss; no detailed clinical information or segregation information was provided for this individual (Chen et al., 2016); Identified in an individual with type II diabetes; no detailed clinical information or segregation information was provided for this individual (Awata et al., 2000); In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; This variant is associated with the following publications: (PMID: 12955714, 31264968, 11317350, 31879078, 33046911, 10679252, 25388789, 27610647, 30174017) |
Fulgent Genetics, |
RCV000515318 | SCV000611534 | uncertain significance | Cataract 41; Wolfram syndrome 1; Autosomal dominant nonsyndromic hearing loss 6; Type 2 diabetes mellitus; Wolfram-like syndrome | 2017-05-23 | criteria provided, single submitter | clinical testing | |
SIB Swiss Institute of Bioinformatics | RCV000677339 | SCV000803617 | uncertain significance | Autosomal dominant nonsyndromic hearing loss 6 | 2018-05-31 | criteria provided, single submitter | curation | This variant is interpreted as a Uncertain Significance - Conflicting Evidence, for Deafness, in Autosomal Dominant manner. The following ACMG Tag(s) were applied: PP3 => Multiple lines of computational evidence support a deleterious effect on the gene or gene product. PP1 => Cosegregation with disease in multiple affected family members in a gene definitively known to cause the disease (PMID:25388789). BS1 => Allele frequency is greater than expected for disorder. |
Illumina Laboratory Services, |
RCV000677339 | SCV001313297 | uncertain significance | Autosomal dominant nonsyndromic hearing loss 6 | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. |
Illumina Laboratory Services, |
RCV001152091 | SCV001313298 | uncertain significance | WFS1-Related Spectrum Disorders | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. |
Invitae | RCV000767006 | SCV001629615 | likely benign | not provided | 2024-01-22 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004534992 | SCV004730114 | likely benign | WFS1-related disorder | 2020-03-03 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Laboratory of Prof. |
RCV000677339 | SCV005073823 | likely pathogenic | Autosomal dominant nonsyndromic hearing loss 6 | 2024-06-13 | criteria provided, single submitter | research | Likely pathogenic by Deafness Variation Databse based on PMID:10679252, 25388789 |